ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it has extended its drug discovery and develop…
Category: News
American Glaucoma Society 22nd Annual Meeting
Read clinically focused news coverage of key developments from the meeting. Medscape Ophthalmology
Hungry People See Food-Related Words More Clearly
Our senses aren’t just delivering a strict view of what’s going on in the world; they’re affected by what’s going on in our heads. A new study finds that hungry people see food-related words more clearly than people who’ve just eaten…
Smartphones and Other Gadgets Help Low Vision
New gadgets can help with the shifting needs of patients with low vision, experts say. Medscape Medical News
“Preservative Toxicity a Disease,” Reports Working Group on Glaucoma Medication Preservatives Toxicity
Valeant Ophthalmics, a division of Valeant Pharmaceuticals North America LLC, announced that the Working Group on Preservatives Toxicity in Glaucoma Medications, an advisory panel of glaucoma treatment experts, was recently convened as an ongoing group…
Photon etc. announces the launch of IRIS, an innovative Retinal Hyperspectral Imaging system
Targeting the emergent field of hyperspectral retinal imaging, Photon etc. is proud to launch IRIS™, a new device for non-invasive localization of biomolecules in the eye fundus. Based on a custom-made mydriatic retinal camera and Photon etc.’s Tun…
How does nearsightedness develop in children?
Myopia (nearsightedness) develops in children when the lens stops compensating for continued growth of the eye, according to a new study.
Antibiotic Use With Intravitreal Injection Unnecessary
As the number of intravitreal injection procedures increases, so will the incidence of injection-related complications, such as endophthalmitis. Attempting to reduce the rate of postinjection endophthalmitis with prophylactic antibiotics is unnecessary…
Novel Technique Using Stem Cells Revives Damaged Eye
Treating blindness caused by burns using limbal stem cells harvested from the undamaged eye of the same patient has now become cheaper, easier and safer. Results of a pilot study of the SLET (simplified technique of limbal transplantation) technique co…
Optogenetic Tool Elucidated
RUB researchers explain channelrhodopsin Controlling nerve cells with the aid of light: this is made possible by optogenetics. It enables, for example, the investigation of neurobiological processes with unprecedented spatial and temporal precision….
Sprint Launches Code Factory Mobile Accessibility Application for Free to Android Users Who Are Blind or Have Low Vision
SAN DIEGO–(BUSINESS WIRE)–Free app is now available, making Android smartphones more accessible for postpaid and no-contract Sprint customers
Femtolaser Technology Improves Accuracy of Cataract Surgery
With femtosecond-LASIK now in routine use for refractive surgery, this technology is poised to become the new standard of care for cataract removal — or will the price be too high? Medscape Medical News
Costs Related to Vision Loss to Exceed $3.5 Trillion by 2020
Costs related to vision loss are expected to skyrocket in the next 10 years as the global population ages. In particular, ocular morbidity related to the diabetes epidemic will increase, according to a study presented here at the World Ophthalmology Co…
FDA Panel Votes No to Single Bottle of Drops for Both Eyes
A US Food and Drug Administration panel has recommended against labeling that would make it appropriate to use 1 bottle of drops for 2 eyes postoperatively. Medscape Medical News
Bevacizumab Prevents Posttrabeculectomy Complications
The antiangiogenesis agent bevacizumab had an 80% success rate in the maintenance of postoperative improvement in intraocular pressure (IOP) after trabeculectomy. In addition, the drug reduced the incidence of subconjunctival scarring, according to fin…
pSivida Corp. Announces Positive Outcome to European Decentralized Procedure for Approval of ILUVIEN® for the Treatment of Chronic Diabetic Macular Edema
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida announces positive outcome to European Decentralized procedure for approval for ILUVIEN for treatment of chronic diabetic macular edema
Dompé enters definitive agreement to acquire Anabasis
Dompé, one of Italy’s leading biopharmaceutical companies, announced today that it has entered into a definitive agreement to acquire 100% of Anabasis Srl, a privately held Italian research and development biopharmaceutical company, focused on ocular …
In Retinoblastoma, Orbit Vascular Anatomy May Affect Outcome
Whether intra-arterial chemotherapy can salvage eyes with retinoblastoma may be affected by the anatomy of orbital blood vessels, according to a new report. “Because of the small volume of drug used (0.50-1.25 mL per treatment) and the selectivity of c…
OptiMedica Begins U.S. Shipments of the Catalys™ Precision Laser System; First U.S. Patients Treated at Mann Eye Institute, Houston
SANTA CLARA, Calif.–(BUSINESS WIRE)–OptiMedica begins shipping the Catalys Precision Laser System for cataract surgery in the U.S. First U.S. patients have been treated at Mann Eye Institute in Houston.
Extend-and-Treat Bevacizumab Regimen Ups Vision in Wet AMD
Patients with wet age-related macular degeneration who received bevacizumab on an extend-and-treat regimen had significantly improved vision, as well as fewer office visits, tests, and injections. Medscape Medical News